Therefore, it is of great interest to develop therapeutic approaches targeting the TRIM15-Keap1 interaction may offer a new therapeutic opportunity to block NSCLC growth and metastasis. The gene discussed is TRIM15; the disease is non-small cell lung carcinoma.